
Started in 2006 as a contract research organization for pharmaceutical and nutrition product R&D, Anthem Biosciences operates state-of-the-art cGMP R&D facilities with more than 800 scientists, serving some of the biggest global pharma companies. Building on its R&D strength, Anthem develops and markets novel, innovative products, and has large-scale synthetic chemistry and fermentation manufacturing capacity, complemented by capabilities such as a high-potency facility, solid-state peptide synthesis plant and flow chemistry reactors to manufacture difficult and innovative products. The company's core strengths span nutritional supplements, enzymes, probiotics and APIs, with a particular focus on vitamin actives within nutrition molecules.

No comments available.
Leave your rating & comment